Financial Ratios

OMKAR PHARMACHEM LTD.

NSE : NABSE : 532167ISIN CODE : INE501C01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE22.400 (0 %)
PREV CLOSE ( ) 22.40
OPEN PRICE ( ) 22.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50
TODAY'S LOW / HIGH ( )22.40 22.40
52 WK LOW / HIGH ( ) 18.4326.25
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.200.180.22-0.26-0.42
   CEPS(Rs)0.200.180.22-0.26-0.41
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.978.778.598.378.63
   Tax Rate(%)25.2213.02716.710.000.10
Margin Ratios
   Core EBITDA Margin(%)57.5949.788.07-454.22
   EBIT Margin(%)57.6549.437.70-458.44
   Pre Tax Margin(%)48.9838.98-13.30-576.89
   PAT Margin (%)36.6333.9182.00-576.89
   Cash Profit Margin (%)37.1334.2682.37-572.67
Performance Ratios
   ROA(%)2.061.932.36-2.78-4.49
   ROE(%)2.212.092.59-3.03-4.72
   ROCE(%)3.202.760.22-2.22-4.11
   Asset Turnover(x)0.060.060.030.000.00
   Sales/Fixed Asset(x)27.4133.1320.933.700.00
   Working Capital/Sales(x)-1.27-0.78-0.30-0.050.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.040.030.050.27
   Receivable days71.1836.5030.42146.00
   Inventory Days0.000.000.000.00
   Payable days
Valuation Parameters
   PER(x)127.42112.330.000.000.00
   PCE(x)125.73111.190.000.000.00
   Price/Book(x)2.792.330.000.000.00
   Yield(%)0.000.00
   EV/Net Sales(x)47.5939.4240.53242.41
   EV/Core EBITDA(x)81.8479.20501.94-53.37-28.02
   EV/EBIT(x)82.5579.76526.07-52.88-27.77
   EV/CE(x)2.692.221.171.171.14
   M Cap / Sales46.6838.090.000.00
Growth Ratio
   Net Sales Growth(%)0.00100.00500.00
   Core EBITDA Growth(%)16.821133.03110.6746.17-60.42
   EBIT Growth(%)16.641183.17110.0846.16-60.17
   PAT Growth(%)8.03-17.30185.2938.22-64.09
   EPS Growth(%)8.04-17.30185.3138.23-64.09
Financial Stability Ratios
   Total Debt/Equity(x)0.070.110.100.100.07
   Current Ratio(x)0.380.300.070.060.03
   Quick Ratio(x)0.380.300.070.060.03
   Interest Cover(x)6.654.730.37-3.87-10.25
   Total Debt/Mcap(x)0.020.05

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.